Stock screenerAll disclosures →
EDGAR →
BJDX
Conviction 28HealthcareScan · Tue, Sep 8, 2026BJDX$1.03+23.14%
ResistanceSupportVol 14Insider buyInsider sellVol MA14 1.85M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price1.03
Change+23.14%
Gap+22.54%
Rel volume14.22×
Avg volume1.4M
Avg $ vol1.35M
SMA 200.9411
SMA 501.08
SMA 2001.77
Price vs 50-5.13%
Price vs 200-42.24%
MA stackbearish
50/200 cross—
Supertrenddown · 1.12
RSI (14)50
MACD hist0.03
MACD cross—
Stoch %K / %D49 / 20
ADX (14)16
+DI / −DI41 / 17
RSI divergence—
MACD divergence—
ATR %+12.74%
ADR %8.57%
52w high5.30
52w low0.6500
From 52w high-80.66%
Above 52w low+57.69%
New 52w highNo
SqueezeOn · 24d
Bollinger width32.88%
%B0.77
Donchian pos49.17%
Donchian high1.24
Donchian low0.8180
AVWAP (52w high)2.09
vs AVWAP high-50.97%
AVWAP (52w low)2.09
vs AVWAP low-50.87%
OBV trendFlat
Chaikin MF (20)-0.24
Today vs 20d14.22×
Avg vol (14d)1.85M
Avg vol (20d)1.4M
Avg $ vol (20d)1.35M
Market cap4.58M
RS 3m (vs SPY)-87.08%
RS 6m (vs SPY)-69.79%
RS line new highNo
Trend template2/8
Technical rank25.5
1 week+17.82%
1 month-4.21%
3 months-80.40%
6 months-45.19%
1 year-29.31%
YTD+56.61%
P/E-0.67
P/B0.49
P/S18.39
P/FCF-0.74
EPS-15.25
Div yield—
ROE-72.74%
ROA-59.38%
Debt/Eq—
Current4.64
EV/EBITDA0.74
Gross margin19.64%
Net margin—
Rev growth0.00%
EPS growth11.26%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-5.02M
Revenue249.04K
Net income-2.32M
Gross profit48.91K
Free cash flow-6.23M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out1.03M
Employees6
ListedWed, Nov 10, 2021
Free float2.35M
Float %90.0%
Short interest51.81K
Days to cover0.0d
Short volume55.2%
Squeeze score30 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction28 / 100
Pattern quality—
Tech rank25.5 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.58
Support0.8240
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upJun 111 scan
- Breaking out nowJun 12 – Jun 152 scans
Recent news
- Bluejay Diagnostics Federal Healthcare Partnership Builds Commercial Pathway Ahead of FDA ClearanceAdvfn · Tue, Sep 8, 2026
- $BJDX stock is up 16% today. Here's what we see in our data.Quiver Quantitative · Tue, Sep 8, 2026
- There are notable gap-ups and gap-downs in today's session.ChartMill · Tue, Sep 8, 2026
- BJDX Stock Draws Traders As Trial, Cash Runway And 13G Alignstockstotrade.com · Tue, Sep 8, 2026
- These stocks are moving in today's pre-market sessionChartMill · Tue, Sep 8, 2026
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga · Tue, Sep 8, 2026
- BJDX Stock Draws Traders As Cash, Trial And 13G AlignStocksToTrade · Tue, Sep 8, 2026
- Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare MarketsYahoo Finance · Tue, Sep 8, 2026
- A medical test company is preparing for about 170 VA medical centers. FDA clearance or authorization comes first.Stock Titan · Tue, Sep 8, 2026
Congress activity
Disclosed STOCK Act trades in BJDX
No recent disclosed trades by Congress in BJDX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BJDX · 7 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
ZEIDMAN FRED S Director · Stock Option (Right to Buy) · 2026-08-17 | Grant | 100K | — | 2026-08-17 | 2026-08-18 |
Dey Svetlana Director · Stock Option (Right to Buy) · 2026-08-17 | Grant | 100K | — | 2026-08-17 | 2026-08-18 |
Wurth Douglas Clark Director · Stock Option (Right to Buy) · 2026-08-17 | Grant | 100K | — | 2026-08-17 | 2026-08-18 |
Dey Indranil President and CEO · Common Stock · 2026-08-17 | Grant | 28K | — | 2026-08-17 | 2026-08-18 |
CHASE DONALD R Director · Stock Option (Right to Buy) · 2026-08-17 | Grant | 100K | — | 2026-08-17 | 2026-08-18 |
HRT FINANCIAL LP 10% owner · Common Stock · 2026-07-10 | Sell | 34.94K | $49K | 2026-07-10 | 2026-07-13 |
HRT FINANCIAL LP 10% owner · Common Stock · 2026-07-09 | Buy | 64.05K | $97K | 2026-07-09 | 2026-07-13 |
Dey Indranil President and CEO · Common Stock · 2026-03-14 | Other | — | — | 2026-03-14 | 2026-05-18 |
Wurth Douglas Clark Director · Common Stock · 2026-03-14 | Buy | 12.5K | $25K | 2026-03-14 | 2026-05-18 |
Dey Svetlana Director · Common Stock · 2026-03-14 | Other | — | — | 2026-03-14 | 2026-05-18 |
SEC filings
EDGAR filings in BJDX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.